Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.
Identifieur interne : 000531 ( Main/Exploration ); précédent : 000530; suivant : 000532Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.
Auteurs : Subhashie Wijemanne [États-Unis] ; Laura J C. Wu ; Joseph Jankovic [États-Unis]Source :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2014.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Child, Child, Preschool, Dopamine Antagonists (adverse effects), Dopamine Antagonists (therapeutic use), Female, Fluphenazine (adverse effects), Fluphenazine (therapeutic use), Humans, Male, Middle Aged, Retrospective Studies, Tourette Syndrome (drug therapy), Treatment Outcome, Young Adult.
- MESH :
- chemical , adverse effects : Dopamine Antagonists, Fluphenazine.
- chemical , therapeutic use : Dopamine Antagonists, Fluphenazine.
- drug therapy : Tourette Syndrome.
- Adolescent, Adult, Aged, Child, Child, Preschool, Female, Humans, Male, Middle Aged, Retrospective Studies, Treatment Outcome, Young Adult.
Abstract
Haloperidol and pimozide are the only drugs currently approved by the U.S. Food and Drug Administration for treatment of Tourette syndrome (TS), but their potential side effects, which include tardive dyskinesia (TD), limit their use.
DOI: 10.1002/mds.25692
PubMed: 24150997
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000703
- to stream PubMed, to step Curation: 000703
- to stream PubMed, to step Checkpoint: 000540
- to stream Ncbi, to step Merge: 003D94
- to stream Ncbi, to step Curation: 003D94
- to stream Ncbi, to step Checkpoint: 003D94
- to stream Main, to step Merge: 000531
- to stream Main, to step Curation: 000531
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.</title>
<author><name sortKey="Wijemanne, Subhashie" sort="Wijemanne, Subhashie" uniqKey="Wijemanne S" first="Subhashie" last="Wijemanne">Subhashie Wijemanne</name>
<affiliation wicri:level="2"><nlm:affiliation>Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wu, Laura J C" sort="Wu, Laura J C" uniqKey="Wu L" first="Laura J C" last="Wu">Laura J C. Wu</name>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation><country>États-Unis</country>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24150997</idno>
<idno type="pmid">24150997</idno>
<idno type="doi">10.1002/mds.25692</idno>
<idno type="wicri:Area/PubMed/Corpus">000703</idno>
<idno type="wicri:Area/PubMed/Curation">000703</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000540</idno>
<idno type="wicri:Area/Ncbi/Merge">003D94</idno>
<idno type="wicri:Area/Ncbi/Curation">003D94</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003D94</idno>
<idno type="wicri:Area/Main/Merge">000531</idno>
<idno type="wicri:Area/Main/Curation">000531</idno>
<idno type="wicri:Area/Main/Exploration">000531</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.</title>
<author><name sortKey="Wijemanne, Subhashie" sort="Wijemanne, Subhashie" uniqKey="Wijemanne S" first="Subhashie" last="Wijemanne">Subhashie Wijemanne</name>
<affiliation wicri:level="2"><nlm:affiliation>Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wu, Laura J C" sort="Wu, Laura J C" uniqKey="Wu L" first="Laura J C" last="Wu">Laura J C. Wu</name>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation><country>États-Unis</country>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Dopamine Antagonists (adverse effects)</term>
<term>Dopamine Antagonists (therapeutic use)</term>
<term>Female</term>
<term>Fluphenazine (adverse effects)</term>
<term>Fluphenazine (therapeutic use)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Tourette Syndrome (drug therapy)</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine Antagonists</term>
<term>Fluphenazine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dopamine Antagonists</term>
<term>Fluphenazine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Tourette Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Haloperidol and pimozide are the only drugs currently approved by the U.S. Food and Drug Administration for treatment of Tourette syndrome (TS), but their potential side effects, which include tardive dyskinesia (TD), limit their use.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Texas</li>
</region>
<settlement><li>Houston</li>
</settlement>
<orgName><li>Baylor College of Medicine</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Wu, Laura J C" sort="Wu, Laura J C" uniqKey="Wu L" first="Laura J C" last="Wu">Laura J C. Wu</name>
</noCountry>
<country name="États-Unis"><region name="Texas"><name sortKey="Wijemanne, Subhashie" sort="Wijemanne, Subhashie" uniqKey="Wijemanne S" first="Subhashie" last="Wijemanne">Subhashie Wijemanne</name>
</region>
<name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000531 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000531 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:24150997 |texte= Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24150997" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |